Quinovare Participation in CPHI Frankfurt 2025
October 2025 | Frankfurt, Germany
Quinovare will participate in CPHI Frankfurt 2025, taking place from October 28–30, 2025. The exhibition brings together global pharmaceutical and biotech stakeholders to discuss development, manufacturing, and delivery technologies across the industry.
During the event, Quinovare’s team will engage in technical and business discussions with pharmaceutical partners regarding needle-free drug delivery platforms and potential collaboration opportunities across vaccines, biologics, insulin, and other injectable therapies.
Quinovare’s needle-free injection system will be available for viewing at Hall 11, Booth 1B39,b> providing an opportunity to review the device architecture, operation principles, and application scenarios relevant to combination product development.
About Quinovare
Quinovare develops needle-free drug delivery platforms designed for pharmaceutical and biotech applications, supporting combination product development, platform adaptation, and regulatory-aligned deployment across multiple therapeutic areas.
Contact Information
For meeting requests during CPHI Frankfurt 2025: